Jiaxing Hengjie Biopharmaceutical Co., Ltd. – Trademark Portfolio
Entity Type: 99
Jiaxing Hengjie Biopharmaceutical Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include MINIPOTE and NATIVE CT-II. The owner is based in Jiaxing City, Zhejiang.
No. 20 Tongyi Road, Xinfeng Town, Nanhu
Jiaxing City, Zhejiang 314001 , CN
Showing of trademarks Trademarks
Trademark Classifications
Jiaxing Hengjie Biopharmaceutical Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Jiaxing Hengjie Biopharmaceutical Co., Ltd. have?
Jiaxing Hengjie Biopharmaceutical Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Jiaxing Hengjie Biopharmaceutical Co., Ltd. file in?
Jiaxing Hengjie Biopharmaceutical Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Jiaxing Hengjie Biopharmaceutical Co., Ltd.'s most well-known trademarks?
Jiaxing Hengjie Biopharmaceutical Co., Ltd.'s registered trademark portfolio includes well-known marks such as MINIPOTE and NATIVE CT-II. These are among 2 currently registered trademarks in the portfolio.
What is Jiaxing Hengjie Biopharmaceutical Co., Ltd.'s trademark registration success rate?
Jiaxing Hengjie Biopharmaceutical Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.